Neurogene NGNE
$25.31 −$0.34 (-1.33%)
Market closed · Nov 6, 8:20 pm ET · Last extended-hours $25.31 0.00%
Open$26.33
Prev close$25.65
Day range$24.68 – $27.26
Volume324.9K
Market cap$506.49M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$36.67M-40.6% YoY
Net profit-$34.49M-56.6% YoY
Diluted EPS-$1.53-45.7% YoY
Free cash flow-$24.12M-23.0% YoY
Operating cash flow-$23.76M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-45.3%
Return on assets-41.0%
Return on invested capital-47.2%
Current ratio10.64
Liabilities / assets11.1%
Cash & investments$225.39M
Total debt$5.73M
Net cash (debt)$219.67M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $36.67M | $33.35M | $103.33M | $27.53M | $23.80M |
| Selling and Admin Expenses | $11.20M | $8.20M | $28.32M | $6.89M | $6.56M |
| -General & Admin Expense | $11.20M | $8.20M | $28.32M | $6.89M | $6.56M |
| Research & Development | $25.47M | $25.15M | $75.01M | $20.64M | $17.24M |
| Operating Profit | -$36.67M | -$33.35M | -$103.33M | -$27.53M | -$23.80M |
| Net Non-Operating Interest Income (Expense) | $2.05M | $2.26M | $11.54M | $2.67M | $2.74M |
| Non-Operating Interest Income | $2.05M | $2.26M | $11.55M | $2.67M | $2.74M |
| Non-Operating Interest Expense | $0.00 | $0.00 | $5,000.00 | $1,000.00 | $1,000.00 |
| Other Income (Expense) | $136,000.00 | $154,000.00 | $1.44M | $122,000.00 | $107,000.00 |
| Other Non-Operating Income (Expenses) | $136,000.00 | $154,000.00 | $1.44M | $122,000.00 | $107,000.00 |
| Pretax Profit | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Net Profit | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Profit from Continuing Operations | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Net Income to Parent Company | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Net Income to Common Stockholders | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Basic EPS | -$1.53 | -$1.39 | -$4.24 | -$1.13 | -$0.99 |
| Diluted EPS | -$1.53 | -$1.39 | -$4.24 | -$1.13 | -$0.99 |
| Total Revenue as Reported | – | $0.00 | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $244.36M | $263.14M | $288.60M | $288.60M | $287.83M |
| Total Current Assets | $228.91M | $246.75M | $271.77M | $271.77M | $270.52M |
| Cash and Cash Equivalents & Short-Term Investments | $225.39M | $243.18M | $269.01M | $269.01M | $265.41M |
| -Cash and Cash Equivalents | $112.49M | $124.16M | $103.85M | $103.85M | $71.01M |
| -Short Term Investments | $112.91M | $119.02M | $165.17M | $165.17M | $194.41M |
| Receivables | $433,000.00 | $250,000.00 | $460,000.00 | $460,000.00 | $860,000.00 |
| -Other Receivables | $433,000.00 | $250,000.00 | $460,000.00 | $460,000.00 | $860,000.00 |
| Prepaid Assets | $2.56M | $2.94M | $1.94M | $1.94M | $3.82M |
| Current Deferred Assets | $393,000.00 | $191,000.00 | $191,000.00 | $191,000.00 | $225,000.00 |
| Other Current Assets | $132,000.00 | $181,000.00 | $168,000.00 | $168,000.00 | $208,000.00 |
| Total Non-Current Assets | $15.45M | $16.39M | $16.83M | $16.83M | $17.31M |
| Net PPE | $14.01M | $14.98M | $15.46M | $15.46M | $15.91M |
| -Gross PPE | $29.78M | $29.93M | $29.57M | $29.57M | $29.34M |
| -Accumulated Depreciation | -$15.77M | -$14.96M | -$14.11M | -$14.11M | -$13.43M |
| Other Non-Current Assets | $1.45M | $1.42M | $1.37M | $1.37M | $1.40M |
| Total Liabilities | $27.23M | $25.36M | $23.72M | $23.72M | $22.29M |
| Total Current Liabilities | $21.51M | $18.87M | $16.41M | $16.41M | $14.71M |
| Payables | $3.29M | $4.69M | $1.95M | $1.95M | $1.54M |
| -Accounts Payable | $3.29M | $4.69M | $1.95M | $1.95M | $1.54M |
| Current Accrued Expenses | $10.01M | $7.95M | $5.12M | $5.12M | $5.23M |
| Short-Term Debt and Capital Lease Obligation | $3.03M | $3.05M | $3.70M | $3.70M | $3.74M |
| -Current Capital Lease Obligation | $3.03M | $3.05M | $3.70M | $3.70M | $3.74M |
| Other Current Liabilities | $1.08M | $947,000.00 | $564,000.00 | $564,000.00 | $328,000.00 |
| Total Non-Current Liabilities | $5.73M | $6.49M | $7.31M | $7.31M | $7.58M |
| Long Term Debt and Capital Lease Obligation | $5.73M | $6.49M | $7.26M | $7.26M | $7.53M |
| -Long Term Capital Lease Obligation | $5.73M | $6.49M | $7.26M | $7.26M | $7.53M |
| Total Equity | $217.13M | $237.78M | $264.89M | $264.89M | $265.54M |
| Stockholders' Equity | $217.13M | $237.78M | $264.89M | $264.89M | $265.54M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $635.20M | $621.37M | $617.54M | $617.54M | $593.45M |
| Retained Earnings | -$418.07M | -$383.58M | -$352.65M | -$352.65M | -$327.91M |
| Other Non-Current Liabilities | – | – | $51,000.00 | $51,000.00 | $51,000.00 |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$23.76M | -$26.12M | -$77.17M | -$17.43M | -$19.51M |
| Net cash flow from continuing operations | -$23.76M | -$26.12M | -$77.17M | -$17.43M | -$19.51M |
| Net Income from Continuing Operations | -$34.49M | -$30.93M | -$90.35M | -$24.74M | -$20.95M |
| Depreciation & Depletion & Amortization | $820,000.00 | $854,000.00 | $3.09M | $787,000.00 | $776,000.00 |
| Other Non-Cash Items | $193,000.00 | -$467,000.00 | $51,000.00 | $189,000.00 | -$615,000.00 |
| Change in Working Capital | $2.20M | $1.17M | $268,000.00 | $3.35M | -$1.27M |
| -Change in Prepaid Assets | $34,000.00 | -$808,000.00 | $952,000.00 | $2.32M | -$417,000.00 |
| -Change in Payables and Accrued Expense | $2.97M | $2.78M | $2.29M | $1.74M | -$136,000.00 |
| -Change in Other Current Assets | -$29,000.00 | -$45,000.00 | -$58,000.00 | $30,000.00 | $33,000.00 |
| -Change in Other Current Liabilities | -$780,000.00 | -$755,000.00 | -$2.92M | -$740,000.00 | -$745,000.00 |
| Net cash flow from investing | $6.10M | $46.24M | $14.00M | $29.61M | $21.99M |
| Net Cash Flow from Continuing Investing Activities | $6.10M | $46.24M | $14.00M | $29.61M | $21.99M |
| Net PPE Purchase and Sale | -$354,000.00 | -$281,000.00 | -$1.18M | -$128,000.00 | -$127,000.00 |
| Net Investment Purchase and Sale | $6.46M | $46.52M | $15.19M | $29.74M | $22.12M |
| Financing Cash Flow | $5.98M | $195,000.00 | $30.43M | $20.66M | $9.71M |
| Net Cash Flow from Continuing Financing Activities | $5.98M | $195,000.00 | $30.43M | $20.66M | $9.71M |
| Net Issuance Payments Of Debt | -$5,000.00 | -$6,000.00 | -$61,000.00 | -$19,000.00 | -$13,000.00 |
| Proceeds from Stock Option Exercised | $89,000.00 | $201,000.00 | $350,000.00 | $174,000.00 | $89,000.00 |
| Ending Cash Balance | $112.82M | $124.50M | $104.18M | $104.18M | $71.34M |
| Net Change in Cash | -$11.68M | $20.32M | -$32.74M | $32.84M | $12.19M |
| Beginning Cash Balance | $124.50M | $104.18M | $136.93M | $71.34M | $59.15M |
| Free Cash Flow | -$24.12M | -$26.40M | -$78.36M | -$17.56M | -$19.64M |
| Net Common Stock Issuance | – | – | $30.38M | $20.58M | $9.80M |
| Net Other Financing Charges | – | – | -$241,000.00 | -$75,000.00 | – |
No comments yet — be the first to weigh in on NGNE.
Sign in to join the discussion.